Global Chuan Bei Qing Fei Tang Jiang Market Growth 2025-2031
Description
The global Chuan Bei Qing Fei Tang Jiang market size is predicted to grow from US$ 51.3 million in 2025 to US$ 67.9 million in 2031; it is expected to grow at a CAGR of 4.8% from 2025 to 2031.
Chuan Bei Qing Fei Tang Jiang is a traditional Chinese medicine preparation, the main ingredients of which include Fritillaria cirrhosa, loquat leaves, platycodon grandiflorum and other Chinese medicinal materials with the effects of moistening the lungs, relieving cough, resolving phlegm and relieving asthma. It is widely used to treat cough, sore throat, phlegm and other symptoms caused by wind-heat or dryness, especially for dry cough without phlegm or sticky phlegm that is difficult to cough up. The syrup has a good taste and is easy to take. It is suitable for people of all ages and is one of the commonly used Chinese patent medicines for relieving respiratory discomfort and promoting recovery.
United States market for Chuan Bei Qing Fei Tang Jiang is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Chuan Bei Qing Fei Tang Jiang is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Chuan Bei Qing Fei Tang Jiang is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Chuan Bei Qing Fei Tang Jiang players cover Hubei Yujindan Pharmaceutical Co., Ltd., Hubei Yanhuang Bencao Pharmaceutical Co., Ltd., Guangxi Gehongtang Pharmaceutical Co., Ltd., Jianmin Pharmaceutical Group Co., Ltd., Jiangxi Chengzhi Yongfeng Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Chuan Bei Qing Fei Tang Jiang Industry Forecast” looks at past sales and reviews total world Chuan Bei Qing Fei Tang Jiang sales in 2024, providing a comprehensive analysis by region and market sector of projected Chuan Bei Qing Fei Tang Jiang sales for 2025 through 2031. With Chuan Bei Qing Fei Tang Jiang sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chuan Bei Qing Fei Tang Jiang industry.
This Insight Report provides a comprehensive analysis of the global Chuan Bei Qing Fei Tang Jiang landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chuan Bei Qing Fei Tang Jiang portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chuan Bei Qing Fei Tang Jiang market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chuan Bei Qing Fei Tang Jiang and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chuan Bei Qing Fei Tang Jiang.
This report presents a comprehensive overview, market shares, and growth opportunities of Chuan Bei Qing Fei Tang Jiang market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
100ml Per Bottle
120ml Per Bottle
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Hubei Yujindan Pharmaceutical Co., Ltd.
Hubei Yanhuang Bencao Pharmaceutical Co., Ltd.
Guangxi Gehongtang Pharmaceutical Co., Ltd.
Jianmin Pharmaceutical Group Co., Ltd.
Jiangxi Chengzhi Yongfeng Pharmaceutical Co., Ltd.
Hubei Meisichuang Pharmaceutical Co., Ltd.
Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd.
Hubei Wushi Pharmaceutical Co., Ltd.
Huiyingbi Group Anhui Pharmaceutical Co., Ltd.
Sunflower Pharmaceutical Group Hubei Wudang Co., Ltd.
Hubei Nordeson Pharmaceutical Co., Ltd.
Wuhan Jianmin Dapeng Pharmaceutical Co., Ltd.
Guangxi Zhengtang Pharmaceutical Co., Ltd.
Guangdong Yihe Pharmaceutical Co., Ltd.
Guangxi Shibiao Pharmaceutical Co., Ltd.
Guangxi Tiantianle Pharmaceutical Co., Ltd.
Guangxi Hercules Pharmaceutical Co., Ltd.
Shanghai Baolong Anqing Pharmaceutical Co., Ltd.
Wuhan Kangle Pharmaceutical Co., Ltd.
Jiangxi Puzheng Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Chuan Bei Qing Fei Tang Jiang market?
What factors are driving Chuan Bei Qing Fei Tang Jiang market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Chuan Bei Qing Fei Tang Jiang market opportunities vary by end market size?
How does Chuan Bei Qing Fei Tang Jiang break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Chuan Bei Qing Fei Tang Jiang is a traditional Chinese medicine preparation, the main ingredients of which include Fritillaria cirrhosa, loquat leaves, platycodon grandiflorum and other Chinese medicinal materials with the effects of moistening the lungs, relieving cough, resolving phlegm and relieving asthma. It is widely used to treat cough, sore throat, phlegm and other symptoms caused by wind-heat or dryness, especially for dry cough without phlegm or sticky phlegm that is difficult to cough up. The syrup has a good taste and is easy to take. It is suitable for people of all ages and is one of the commonly used Chinese patent medicines for relieving respiratory discomfort and promoting recovery.
United States market for Chuan Bei Qing Fei Tang Jiang is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Chuan Bei Qing Fei Tang Jiang is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Chuan Bei Qing Fei Tang Jiang is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Chuan Bei Qing Fei Tang Jiang players cover Hubei Yujindan Pharmaceutical Co., Ltd., Hubei Yanhuang Bencao Pharmaceutical Co., Ltd., Guangxi Gehongtang Pharmaceutical Co., Ltd., Jianmin Pharmaceutical Group Co., Ltd., Jiangxi Chengzhi Yongfeng Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Chuan Bei Qing Fei Tang Jiang Industry Forecast” looks at past sales and reviews total world Chuan Bei Qing Fei Tang Jiang sales in 2024, providing a comprehensive analysis by region and market sector of projected Chuan Bei Qing Fei Tang Jiang sales for 2025 through 2031. With Chuan Bei Qing Fei Tang Jiang sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Chuan Bei Qing Fei Tang Jiang industry.
This Insight Report provides a comprehensive analysis of the global Chuan Bei Qing Fei Tang Jiang landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Chuan Bei Qing Fei Tang Jiang portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Chuan Bei Qing Fei Tang Jiang market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Chuan Bei Qing Fei Tang Jiang and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Chuan Bei Qing Fei Tang Jiang.
This report presents a comprehensive overview, market shares, and growth opportunities of Chuan Bei Qing Fei Tang Jiang market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
100ml Per Bottle
120ml Per Bottle
Segmentation by Application:
Hospital
Clinic
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Hubei Yujindan Pharmaceutical Co., Ltd.
Hubei Yanhuang Bencao Pharmaceutical Co., Ltd.
Guangxi Gehongtang Pharmaceutical Co., Ltd.
Jianmin Pharmaceutical Group Co., Ltd.
Jiangxi Chengzhi Yongfeng Pharmaceutical Co., Ltd.
Hubei Meisichuang Pharmaceutical Co., Ltd.
Jiangxi Tonggu Renhe Pharmaceutical Co., Ltd.
Hubei Wushi Pharmaceutical Co., Ltd.
Huiyingbi Group Anhui Pharmaceutical Co., Ltd.
Sunflower Pharmaceutical Group Hubei Wudang Co., Ltd.
Hubei Nordeson Pharmaceutical Co., Ltd.
Wuhan Jianmin Dapeng Pharmaceutical Co., Ltd.
Guangxi Zhengtang Pharmaceutical Co., Ltd.
Guangdong Yihe Pharmaceutical Co., Ltd.
Guangxi Shibiao Pharmaceutical Co., Ltd.
Guangxi Tiantianle Pharmaceutical Co., Ltd.
Guangxi Hercules Pharmaceutical Co., Ltd.
Shanghai Baolong Anqing Pharmaceutical Co., Ltd.
Wuhan Kangle Pharmaceutical Co., Ltd.
Jiangxi Puzheng Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Chuan Bei Qing Fei Tang Jiang market?
What factors are driving Chuan Bei Qing Fei Tang Jiang market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Chuan Bei Qing Fei Tang Jiang market opportunities vary by end market size?
How does Chuan Bei Qing Fei Tang Jiang break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
140 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Chuan Bei Qing Fei Tang Jiang by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Chuan Bei Qing Fei Tang Jiang by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
